The outcome of a recent online survey carried out in India on self-reported adverse events following COVID-19 vaccination

Smita Nayak, Ashish Babtiwale, Hemangi Padhye, Bhaskar Vaidhun
2022 German Journal of Pharmaceuticals and Biomaterials  
The last two years have been mainly in the grip of the coronavirus pandemic. In record time, the healthcare sector has worked tirelessly to introduce the COVID-19 vaccines. As the pandemic continues to rage, the pace of vaccination is being increased to reduce the aftermath of the destruction caused by the virus. Information about the adverse events experienced post-vaccination will help further improve vaccines. The objective of this study was to collect data on adverse events experienced
more » ... wing COVID-19 vaccination in India to assess these vaccines' tolerability and apparent safety. In order to analyse adverse effects post-vaccination, a questionnaire was developed for an online survey. A pilot was carried out and posted online. Responses from 722 respondents were collected between May 2021 to December 2021 and analysed with the help of excel analytics and statistics in a scientific manner. The survey revealed that less than 50% of the vaccinated respondents experienced adverse effects after the first dose of COVID vaccines. Perceived side effects included pain, redness, swelling, headache, body ache, muscle pain, joint pain, tiredness, lethargy, chills, fever, nausea, giddiness, and diarrhoea. Less than 1% of the respondents were reportedly hospitalized for alleviation of their symptoms post-vaccination (first and second doses). The rest recovered from the side effects with none to minimal treatment on an outpatient basis. The vaccines under study elicited side effects in less than 50% of the respondents and were well-tolerated overall.
doi:10.5530/gjpb.2022.2.9 fatcat:eqeezia5ufb4hotlw2a2mkemtq